EPIX and XOMA Related Headlines
Go Back- ESSA Pharma amends deal terms, cuts shareholder payout to $0.12 per share
- ESSA Pharma Inc. Amends Agreement with XenoTherapeutics
- ESSA Pharma to be acquired by XenoTherapeutics in all-cash deal
- ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction
EPIX and XOMA Related Press Releases
Go Back- ESSA Pharma Inc. Amends Agreement with XenoTherapeutics
- ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction
